Short Interest in BioStem Technologies, Inc. (OTCMKTS:BSEM) Expands By 20.5%

BioStem Technologies, Inc. (OTCMKTS:BSEM) saw a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 170,200 shares, an increase of 20.5% from the March 15th total of 141,300 shares. Based on an average daily trading volume, of 85,600 shares, the days-to-cover ratio is presently 2.0 days. Approximately 1.0% of the company’s shares are short sold.

BioStem Technologies Stock Performance

BioStem Technologies stock opened at $11.38 on Wednesday. The stock has a market capitalization of $190.08 million, a price-to-earnings ratio of 16.74 and a beta of 0.09. BioStem Technologies has a 52-week low of $6.77 and a 52-week high of $28.26. The stock’s 50 day moving average price is $11.14 and its two-hundred day moving average price is $13.78.

BioStem Technologies Company Profile

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.